Publication | Open Access

Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer’s disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase

Neurodegenerative DiseasesMedicinal ChemistryAlzheimer's DiseaseBiochemistryMedicineNatural SciencesType-ii Diabetes MellitusPharmacological AgentPyridine SulfonamideDrug DevelopmentChemical BiologyPharmacologyPharmaceutical ChemistryInhibitory ActivityDrug DiscoveryPotential Treatment